Evidence map›Paper›PMID 31511636›Full record

ArticleMolecular psychiatry2020

White matter abnormalities across the lifespan of schizophrenia: a harmonized multi-site diffusion MRI study.

Suheyla Cetin-Karayumak, Maria A Di Biase, Natalia Chunga, Benjamin Reid, Nathaniel Somes, Amanda E Lyall, Sinead Kelly, Bengisu Solgun, Ofer Pasternak, Mark Vangel and 21 more

Open access · greenAbstract read
In one paragraph

Article in Molecular psychiatry, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 107 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
107citing papers in PubMed, 5 pooled it
15.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

107 citing papers in PubMed, 5 syntheses or guidelines pooled it, 179 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Review
  7. Article
  8. Multiscale Heterogeneity of White Matter Morphometry in Psychiatric Disorders.Biological psychiatry. Cognitive neuroscience and neuroimaging · 2026
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

47 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

31 authors at 16 institutions in 6 countries.

Suheyla Cetin-KarayumakDepartment of Psychiatry, Brigham and Women's Hospital, Harvard Medical School, MA, Boston, USA. skarayumak@bwh.harvard.edu.
Maria A Di BiaseDepartment of Psychiatry, Brigham and Women's Hospital, Harvard Medical School, MA, Boston, USA.
Natalia ChungaDepartment of Psychiatry, Brigham and Women's Hospital, Harvard Medical School, MA, Boston, USA.ORCID http://orcid.org/0000-0001-8450-7121
Benjamin ReidDepartment of Psychiatry, Brigham and Women's Hospital, Harvard Medical School, MA, Boston, USA.
Nathaniel SomesDepartment of Psychiatry, Brigham and Women's Hospital, Harvard Medical School, MA, Boston, USA.
Amanda E LyallDepartment of Psychiatry, Brigham and Women's Hospital, Harvard Medical School, MA, Boston, USA.ORCID http://orcid.org/0000-0001-8049-516X
Sinead KellyDepartment of Psychiatry, Brigham and Women's Hospital, Harvard Medical School, MA, Boston, USA.
Bengisu SolgunHacettepe Medical School, Altındağ, Turkey.
Ofer PasternakDepartment of Psychiatry, Brigham and Women's Hospital, Harvard Medical School, MA, Boston, USA.
Mark VangelDepartment of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Godfrey PearlsonDepartment of Psychiatry, Yale University, New Haven, CT, USA.
Carol TammingaDepartment of Psychiatry, UT Southwestern Medical Center, Dallas, TX, USA.
John A SweeneyDepartment of Psychiatry and Behavioral Neuroscience, University of Cincinnati, Cincinnati, OH, USA.
Brett ClementzDepartments of Psychology and Neuroscience, Bio-Imaging Research Center, University of Georgia, Athens, USA.
David SchretlenDepartment of Psychiatry and Behavioral Sciences, Morgan Department of Radiology and Radiological Science, Johns Hopkins Medical Institutions, Baltimore, USA.ORCID http://orcid.org/0000-0003-3992-5601
Petra Verena ViherUniversity of Bern, University Hospital of Psychiatry, Bern, Switzerland.
Katharina StegmayerUniversity of Bern, University Hospital of Psychiatry, Bern, Switzerland.
Sebastian WaltherUniversity of Bern, University Hospital of Psychiatry, Bern, Switzerland.
Jungsun LeeDepartment of Psychiatry, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.
Tim CrowDepartment of Psychiatry, SANE POWIC, Warneford Hospital, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0002-5482-6655
Anthony JamesDepartment of Psychiatry, SANE POWIC, Warneford Hospital, University of Oxford, Oxford, UK.
Aristotle VoineskosCentre for Addiction and Mental Health; Department of Psychiatry, University of Toronto, Toronto, Canada.
Robert W BuchananMaryland Psychiatric Research Center, Catonsville, USA.
Philip R SzeszkoDepartment of Psychiatry, Icahn School of Medicine at Mount Sinai; Mental Illness Research, Education and Clinical Center, James J. Peters VA Medical Center, New York, USA.
Anil K MalhotraThe Feinstein Institute for Medical Research and Zucker Hillside Hospital, Manhasset, USA.
Rachal HegdeDepartment of Psychiatry, Beth Israel Deaconess Medical Centre, Harvard Medical School, Boston, MA, USA.
Robert McCarley
Matcheri KeshavanDepartment of Psychiatry, Beth Israel Deaconess Medical Centre, Harvard Medical School, Boston, MA, USA.
Martha ShentonDepartment of Psychiatry, Brigham and Women's Hospital, Harvard Medical School, MA, Boston, USA.
Yogesh RathiDepartment of Psychiatry, Brigham and Women's Hospital, Harvard Medical School, MA, Boston, USA.
Marek KubickiDepartment of Psychiatry, Brigham and Women's Hospital, Harvard Medical School, MA, Boston, USA.
Brigham and Women's Hospital · USUniversity of Bern · CHBeth Israel Deaconess Medical Center · USUniversity of Maryland, Baltimore · USWarneford Hospital · GBCentre for Addiction and Mental Health · CAFeinstein Institute for Medical Research · USHacettepe University · TRHarvard University · USJames J. Peters VA Medical Center · USJohns Hopkins University · USSouthwestern Medical Center · USUlsan College · KRUniversity of Cincinnati · USUniversity of Georgia · USYale University · US

Funding

Striatal D2/D3 Dopamine receptor availability in first episode schizophreniaP50MH080173 · NIMH · FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH · PI KANE, JOHN M · 2008 to 2012
$10.4M
Trials Operation Unit (OPERATIONS CORE)P30MH090590 · NIMH · FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH · PI CORRELL, CHRISTOPH U · 2010 to 2014
$7.9M
Bipolar & Schizophrenia Consortium for Parsing Intermediate PhenotypesR01MH077851 · NIMH · UT SOUTHWESTERN MEDICAL CENTER · PI TAMMINGA, CAROL A · 2007 to 2019
$7.8M
Bipolar & Schizophrenia Consortium for Parsing Intermediate PhenotypesR01MH077945 · NIMH · YALE UNIVERSITY · PI PEARLSON, GODFREY D · 2007 to 2019
$7.6M
Stability of Biotypes: a Longitudinal EvaluationR01MH078113 · NIMH · WAYNE STATE UNIVERSITY · PI KESHAVAN, MATCHERI S. · 2007 to 2019
$6.2M
Human Connectome Project for Early PsychosisU01MH109977 · NIMH · BRIGHAM AND WOMEN'S HOSPITAL · PI BREIER, ALAN, SHENTON, MARTHA E. · 2016 to 2020
$5.5M
Harmonizing multi-site diffusion MRI acquisitions for neuroscientific analysis across ages and brain disordersR01MH119222 · NIMH · BRIGHAM AND WOMEN'S HOSPITAL · PI O'DONNELL, LAUREN JEAN, RATHI, YOGESH · 2019 to 2023
$4.0M
Bipolar & Schizophrenia Consortium for Parsing Intermediate PhenotypesR01MH077852 · NIMH · UNIVERSITY OF MARYLAND BALTIMORE · PI THAKER, GUNVANT K · 2007 to 2010
$3.5M
Bipolar & Schizophrenia Consortium for Parsing Intermediate PhenotypesR01MH077862 · NIMH · UT SOUTHWESTERN MEDICAL CENTER · PI SWEENEY, JOHN A · 2007 to 2010
$3.1M
Brain Imaging, Cognitive Enhancement and Early SchizophreniaR01MH092440 · NIMH · BETH ISRAEL DEACONESS MEDICAL CENTER · PI KESHAVAN, MATCHERI S. · 2012 to 2016
$3.1M
Diffusion Imaging Biomarkers for Risk, Onset and Outcome in SchizophreniaR01MH102377 · NIMH · BRIGHAM AND WOMEN'S HOSPITAL · PI KUBICKI, MAREK · 2014 to 2018
$2.8M
Taking advanced diffusion imaging to the clinic for pediatric patients with ADHDR01MH097979 · NIMH · BRIGHAM AND WOMEN'S HOSPITAL · PI RATHI, YOGESH · 2012 to 2017
$2.4M
Medical Research Council G0500092NIMH NIH HHS K01 MH115247NIMH NIH HHS K24 MH110807NIMH NIH HHS P30 MH090590NIMH NIH HHS P50 MH080173NIMH NIH HHS R01 MH076995NIMH NIH HHS R01 MH077851NIMH NIH HHS R01 MH077852NIMH NIH HHS R01 MH077862NIMH NIH HHS R01 MH077945NIMH NIH HHS R01 MH078113NIMH NIH HHS R01 MH092440NIMH NIH HHS R01 MH097979NIMH NIH HHS R01 MH102377NIMH NIH HHS R01 MH108574NIMH NIH HHS R01 MH119222NIMH NIH HHS R03 MH110745NIMH NIH HHS U01 MH109977
6 · The paper itself

Abstract

Several prominent theories of schizophrenia suggest that structural white matter pathologies may follow a developmental, maturational, and/or degenerative process. However, a lack of lifespan studies has precluded verification of these theories. Here, we analyze the largest sample of carefully harmonized diffusion MRI data to comprehensively characterize age-related white matter trajectories, as measured by fractional anisotropy (FA), across the course of schizophrenia. Our analysis comprises diffusion scans of 600 schizophrenia patients and 492 healthy controls at different illness stages and ages (14-65 years), which were gathered from 13 sites. We determined the pattern of age-related FA changes by cross-sectionally assessing the timing of the structural neuropathology associated with schizophrenia. Quadratic curves were used to model between-group FA differences across whole-brain white matter and fiber tracts at each age; fiber tracts were then clustered according to both the effect-sizes and pattern of lifespan white matter FA differences. In whole-brain white matter, FA was significantly lower across the lifespan (up to 7%; p < 0.0033) and reached peak maturation younger in patients (27 years) compared to controls (33 years). Additionally, three distinct patterns of neuropathology emerged when investigating white matter fiber tracts in patients: (1) developmental abnormalities in limbic fibers, (2) accelerated aging and abnormal maturation in long-range association fibers, (3) severe developmental abnormalities and accelerated aging in callosal fibers. Our findings strongly suggest that white matter in schizophrenia is affected across entire stages of the disease. Perhaps most strikingly, we show that white matter changes in schizophrenia involve dynamic interactions between neuropathological processes in a tract-specific manner.

Indexed as

SchizophreniaWhite MatterAdolescentAdultAgedAnisotropyBrainDiffusion Magnetic Resonance ImagingDiffusion Tensor ImagingHumansLongevityMiddle AgedYoung Adult

Identifiers

PMID31511636
PMCPMC7147982
OpenAlexW2972389188

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.